To investigate the hypothesis that combined treatment enhances p53 transcriptional activity in ALL cells, we assessed the mRNA expression levels of several candidate genes associated with cell cycle arrest and apoptosis using qRT-PCR. The gene discussed is TP53; the disease is acute lymphoblastic leukemia.